World News 360
ad now
loading...
media venus
Sunday, 30 August 2020
ESC: AstraZeneca's Farxiga cuts kidney disease risks by 39% in trial that could 'rewrite' the treatment textbook - FiercePharma
ESC: AstraZeneca's Farxiga cuts kidney disease risks by 39% in trial that could 'rewrite' the treatment textbook
FiercePharma
View Full Coverage on Google News
from Business - Latest - Google News https://ift.tt/2YOit89
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment